Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patients-Reference-Cited by-同舟云学术

Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patients

Published:2021-12-19 Issue:2 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Faraji Hannaneh¹²,Daneshpazhooh Maryam¹²^ORCID,Ehsani Amir Hooshang¹²,Mahmoudi Hamidreza¹²^ORCID,Tavakolpour Soheil¹²³^ORCID,Aryanian Zeinab¹²⁴,Aslani Saeed⁵,Khodaveisi Hamidreza¹²,Balighi Kamran¹²

Affiliation:

1. Department of Dermatology Razi Hospital, Tehran University of Medical Sciences Tehran Iran

2. Autoimmune Bullous Diseases Research Center Razi Hospital, Tehran University of Medical Sciences Tehran Iran

3. Dana‐Farber Cancer Institute Harvard Medical School Boston Massachusetts USA

4. Department of Dermatology Babol University of Medical Sciences Babol Iran

5. Department of Immunology School of Medicine, Tehran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15257

Reference33 articles.

1. Current concepts of pemphigus with a deep insight into its molecular aspects

2. The molecular aspects of oral mucocutaneous diseases: a review;Sangeetha S;Int J Genet Mol Biol,2011

3. Immunopathogenesis of pemphigus vulgaris: A brief review

4. Geoepidemiologic considerations of auto-immune pemphigus

5. Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections in the era of immunobiologicals;Anais Brasileiros de Dermatologia;2024-03

2. Pneumocystis jiroveci and cytomegalovirus infection in a pemphigus patient treated with rituximab: a case report and literature review;2023-07-06

3. Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study;Dermatology and Therapy;2023-06-15

4. Various infections in patients with autoimmune bullous diseases: a retrospective case-control study;2023-04-18

5. Pemphigus for the Inpatient Dermatologist;Current Dermatology Reports;2022-09-02